SCHEMBL6967758

SCHEMBL6967758

O=C(O)[C@@H]1CCCCN1c1nc2ccccc2s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.51
NPC1 O15118 7/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
MAPT P10636 3/20 0.51
TP53 P04637 1/20 0.51
KMT2A Q03164 3/20 0.47
LMNA P02545 3/20 0.46
MAPK1 P28482 2/20 0.46
ALDH1A1 P00352 2/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.45
MAOB P27338 1/20 0.44
OGFRL1 Q5TC84 1/20 0.43
GAA P10253 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1199326 0.96 NPC1 (0.52) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL11985482 0.96 NPC1 (0.52) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL22896950 0.87 NPC1 (0.51) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL20027984 0.87 NPC1 (0.51) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL11985494 0.85 NPC1 (0.51) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL6973188 0.83 NPC1 (0.56) RAB9ANPC1SMN1; SMN2MAPTLMNA
SCHEMBL27479846 0.83 MAPT (0.48) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL2072963 0.75 RAB9A (0.71) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL9033466 0.74 RAB9A (0.49) RAB9ANPC1SMN1; SMN2MAPTTP53
SCHEMBL9033462 0.74 RAB9A (0.49) RAB9ANPC1SMN1; SMN2MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1611499-A Heterocyclic compounds as inhibitors of rotamase enzymes PFIZER (US) 2005-05-04 CN disclosed
CN-1174978-C Heterocyclic compounds useful as rotamase inhibitors 2004-11-10 CN disclosed
CN-1511837-A Intermediate for heterocyclic compound in preparing rotamase inhibitor 2004-07-14 CN disclosed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed
CN-1310718-A Heterocyclic compounds useful as rotamase inhibitors PFIZER LTD (US) 2001-08-29 CN disclosed
EP-1100797-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES Pfizer Limited (GB) 2001-05-23 EP disclosed
WO-2000005232-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LIMITED (GB) 2000-02-03 WO disclosed